{"name":"Relmada Therapeutics, Inc.","slug":"relmada-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOaGZpc2lURHBrWG80eGYtS1RPLThVQmZOWW5aajlyTnpsLTNyM2RWUDJLWUJyRVZBRmxKN0tseEtEc1ZORWNtNVRtQzZrWXBkVjNtME1TUkRUaXJZVU91M1FNOS1IeDd5ZTJKbmh4ZUs1a1d4ZW9tdU04RzZNNzFlOWNPRDZMai1NWFB5bzVGQm9pVmJ6VlRYZ1Zvc0NwMF9IcnBFY3IxUWF1c3hYMS1GTw?oc=5","date":"2026-04-06","type":"pipeline","source":"Yahoo Finance","summary":"Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics - Yahoo Finance","headline":"Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Ther","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE01U2JMSUcxX1ZIQlZRVmNMcGVXWFU5MjNDNXBDUFhlU3lWLXNwYkJfY3Fha3JyU29hNDUwWi1LbTRsMU9VYmpVeFhQY0QtMDE3Y1FwdkRwV1ZkWkFaNFNGV0drd9IBY0FVX3lxTE01U2JMSUcxX1ZIQlZRVmNMcGVXWFU5MjNDNXBDUFhlU3lWLXNwYkJfY3Fha3JyU29hNDUwWi1LbTRsMU9VYmpVeFhQY0QtMDE3Y1FwdkRwV1ZkWkFaNFNGV0drdw?oc=5","date":"2026-04-06","type":"pipeline","source":"Bitget","summary":"Zacks Industry Outlook Features Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics, and Avalo Therapeutics - Bitget","headline":"Zacks Industry Outlook Features Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPdHhNY2FMMjd6dGpyb2M1Q0kyMkgtOXhFYkNWQ1M4ZVhfVlpmY2sxcHh3V2NLcU1wZ21Pci1xUVo5Sm1qc1dhTGs0SllUejRqcDJuS3JzTG5OMFlGV2g5WjZTUThmMWtmblJMV2lrQl9vX2JEUmlhVnRkSVE0UHZvenUzM3A3OHRkYzNhRDBRN2VzQk95aHh3eEU2alBOci1rbWIyN3ZPVmdpa25tNGc?oc=5","date":"2026-03-30","type":"pipeline","source":"Seeking Alpha","summary":"Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD) - Seeking Alpha","headline":"Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNazdYWHpHRHNyZjVPTXdGeF9hRVVCbEZkN2cwM2lSZnFlTXJoNHl0bUVwaXFFYXdtTkVFdG5GdjBKTkZfbXVlSk9CWF9xdU1Nb1JVOF9lLUllQVFwcUlyU3cyNVVvQXdXREQyTktxS0tpX0g5Y05UdXYxMzVIZVlnMTBCUFRtZndxLUg2cVJtV0NlbmlIbmpLc3Uzb01kLXlWb213bUwtVkliV0tHVWNydg?oc=5","date":"2026-03-19","type":"pipeline","source":"Stock Titan","summary":"Relmada (NASDAQ: RLMD) pivots to NDV-01 cancer drug and sepranolone - Stock Titan","headline":"Relmada (NASDAQ: RLMD) pivots to NDV-01 cancer drug and sepranolone","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPVVo1Y25Bb1FYNmZkME5QMThVQjJmNVR5M01IdU5pbmoxT2VTQmM0SU05cl9RX2Mtbkt1TWVXREtLSUQ5WW1aVlNzVzFaMmtubjNzVTRWaHNjbVVhcUJibVNaRS1UbHYtaEJaUW5uSHZDOUdDUHlLcWR1eGdhcjJlNnliYk5UTGI4dFdCWThMbXJSWkhEbUpkZjFhVnVDb05raVZ4TUFxZVV2RnVkSEZ4bjFieG1TeHZFQTh5dXlDTmpzc0REbkNialotd3ZSRjRhS2Npa1Q1OXRYcFhNX0RabFBOM2ZHWG8wYWVqbEp1eHdaRmU0TVlCN05R?oc=5","date":"2026-03-12","type":"earnings","source":"GlobeNewswire","summary":"Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026 - GlobeNewswire","headline":"Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNZFhobEYyVlpka3FaNFRGSUNBOGJUUnVmS245NW9PYXN1aWlKY01jUVdqZUN3UW1PMDVEbktQcDZORVktYktUcVpwRnhzb1dzLURvRlpUSjQ0RnF0bmIzZ0doMUNTYndTVkVaSE45ZFlMeTZKblYxdnBtaUc1VTVPbVkxSkI1c29LRzFVcGEtVjhHNmJOWkJZaXc3QnpnVGZKX29VSmppZEVtZF9wMkZrdDNINy0?oc=5","date":"2026-03-09","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Monday's Pre-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOS1NOUUt1QmlmSk1RMTlRMks3YzJlZ21hVlk3d2xhdElIaFFoWXk1MVZEZFV3QnFPaTJ4N2p6R2FJQ29XUy13bF9jZmpWYlM2VWk1OHZrT0g5T2VLaG8ycHk3WTVQZF8ycG13Z1p6Q082Y2tXVEdYSGNQWUxHeTZNeVBCdVQ2RFBTQ2ZiLUZmc3JYYjlmbUR5ZlFDdlJOemJqbWRfTVY4VHFPbTRnQVhwSTZn?oc=5","date":"2026-03-09","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Monday's Intraday Session - Acurx Pharmaceuticals (NASDAQ:ACXP), Firefly - Benzinga","headline":"12 Health Care Stocks Moving In Monday's Intraday Session - Acurx Pharmaceuticals (NASDAQ:ACXP), Firefly","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOMkcxSkRyaW1yS2hpaXdxVVN0YlVwX1Y5bnB1TjJFMVZZckdwMW5JakpGWFhMTVdGSExjSGxzN0ZDb2hXZGxXTTRWeUhlLVQ4bm1xLTFYZkR2SjA0M3drdDBXYjhYMkdZVDRKR05TT08xcVo1b3RndFBpREpQd2hDRDRGaE9hdGVMdy0tQXVXUXBrbU5iYm1fQ1ZSSW9ldFNUaGo0V1RDek9TTzlmZUhfa0tsNEhWRzZUQ2g3U05MUQ?oc=5","date":"2026-03-09","type":"pipeline","source":"Stock Titan","summary":"Biotech Relmada secures $160M private raise for drug R&D and operations - Stock Titan","headline":"Biotech Relmada secures $160M private raise for drug R&D and operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPZ2xOWTFGdGFyaVR6VC1HQkhkSDdoUDRtanJ5X2xQQWFjZHhmVXdSZWo0dVpKQy03TEd3SXY0YUM3eS10aE5FWm1TSExXUnlsY1Z2UkZBb2plOUxJektXdXhWdWQxejBKLW1CNFVFNGFQVGcyZjE3QXpzTmNRdmxDVzAxRi1LeUktMU1teVZSN05RUjBjbUpsREFRMHFXWUtMZ3NVMktxLWE4RTRV?oc=5","date":"2025-07-11","type":"trial","source":"Fierce Biotech","summary":"Relmada terminates license agreement for troubled phase 3 depression asset - Fierce Biotech","headline":"Relmada terminates license agreement for troubled phase 3 depression asset","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-29","type":"pipeline","source":"simplywall.st","summary":"Insider Purchases Worth US$1.10m See Losses As Relmada Therapeutics Market Value Drops To US$20m - simplywall.st","headline":"Insider Purchases Worth US$1.10m See Losses As Relmada Therapeutics Market Value Drops To US$20m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1TVGgwbTlZWl9xQ19RZjZKR3Vlbm5udTU5S2VyUEYxcDgxYVZDOTlQY0RuT3kxenRsaG1wbkQ0Z3dOWU4teC0zYTlWVGdSVE9RdVlOTWV0eXg1anNzWjBvaGhVY1hLeGZmZWpCcHVjMkluRlVYbTk5eEZXcEFYQQ?oc=5","date":"2025-02-07","type":"deal","source":"Pharmaceutical Technology","summary":"Relmada acquires Tourette syndrome therapy rights from Asarina - Pharmaceutical Technology","headline":"Relmada acquires Tourette syndrome therapy rights from Asarina","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNVmdJTzNXNEN3SzN6ODViUkUxQVpTVTAyd2JpQzdnZXdIcHhoWTNsZFk0SmJQZFZzN2wwVEFiSk52SHRYSXZBaWEyemQwOXFwRmNCdFRWbEtUU1RPS0Y4VjU3ckk3MkNRR0p6UmstSFg3Vi1Ha05RVXVDUTViZFJzZllCR1VLSFE0ZTRXSWFLY1gyY2k3Wmw4b0FUZ1B4UjJJSUpYaHItRFd0ZlJUOEloTms2dW5qLVJ1RllRRmV3?oc=5","date":"2021-02-09","type":"deal","source":"St. John's University","summary":"College of Pharmacy and Health Sciences Partners with Relmada Therapeutics, Inc. - St. John's University","headline":"College of Pharmacy and Health Sciences Partners with Relmada Therapeutics, Inc. - St. John's University","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}